A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104
A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104
Recruiting · NCT07395739 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104 | Neisseria Meningitidis Serogroup B | Recruiting | Phase 1 | 2026-04-06 | NCT07395739 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Linear Early Phase Limited | Perth | Australia | 1 |